Sinarest Tablet: Paracetamol + Phenylephrine + Chlorpheniramine for Sinus Congestion
Clinical review of Sinarest tablet: sinus headache relief, facial pressure, blocked nose, sneezing, adult dosing intervals, and generic savings.
Sinarest is a frontline remedy for acute sinus headaches, rhinorrhea, and nasal blockage. It contains Paracetamol (500mg), Phenylephrine (10mg), and Chlorpheniramine Maleate (2mg). It relieves sinus pressure while reducing fever and headache.
1. Sinus Pressure Decongestion
Inflamed sinus cavities become blocked when nasal mucosal linings swell. Phenylephrine constricts local mucosal capillaries, opening the sinus ostia and allowing trapped mucus to drain freely.
2. Dosage and Frequency
For adults, 1 tablet every 6 to 8 hours after food. Do not exceed 3 to 4 tablets in 24 hours. Limit use to 3 to 5 consecutive days.
3. Generic Price Comparison
Branded Sinarest costs ~₹65 for a strip of 10. The Jan Aushadhi generic equivalent costs ₹11.00 (83% savings).
Top 8 Essential Indian Medicines: Branded MRP vs. Jan Aushadhi Generic Comparison
Compare average Indian retail MRP of top branded formulations against government-certified PMBJP Jan Aushadhi bioequivalent generic prices and active salts. Verified against official PMBJP formularies, NPPA price caps, and CDSCO regulatory registries.
| Brand Name | Leading Manufacturer | Active Salt Formulation (IP) | Branded MRP | Jan Aushadhi Price | Savings % |
|---|---|---|---|---|---|
| Augmentin 625 Duo | GlaxoSmithKline Pharmaceuticals | Amoxicillin Trihydrate 500mg + Potassium Clavulanate 125mg IP | ₹220.00 | ₹58.00 | 74% |
| Dolo 650 | Micro Labs Ltd | Paracetamol (Acetaminophen) 650mg IP | ₹34.00 | ₹5.50 | 84% |
| Pantocid 40 | Sun Pharmaceutical Industries | Pantoprazole Sodium 40mg IP (Gastro-resistant) | ₹155.00 | ₹8.00 | 95% |
| Azithral 500 | Alembic Pharmaceuticals | Azithromycin Dihydrate 500mg IP | ₹132.00 | ₹24.00 | 82% |
| Glycomet 500 | USV Private Limited | Metformin Hydrochloride 500mg IP | ₹24.00 | ₹4.50 | 81% |
| Shelcal 500 | Torrent Pharmaceuticals | Elemental Calcium 500mg + Cholecalciferol (Vit D3) 250 IU IP | ₹134.00 | ₹16.00 | 88% |
| Telma 40 | Glenmark Pharmaceuticals | Telmisartan 40mg IP | ₹92.00 | ₹7.50 | 92% |
| Montair-LC | Cipla Ltd | Montelukast Sodium 10mg + Levocetirizine Dihydrochloride 5mg IP | ₹210.00 | ₹18.00 | 91% |
| Combined 8-Drug Essential Therapy Basket Total: | ₹1,001.00 | ₹141.00 | 85.9% Net Savings | ||
Frequently Asked Questions (Clinical & Regulatory)
Q1: Can Sinarest keep me awake at night?
Phenylephrine can cause mild stimulation in some individuals, though the drowsy antihistamine (CPM) usually counterbalances it.
Q2: Can Sinarest cure bacterial sinus infections?
Sinarest relieves symptoms, but if sinus pain persists past 7 days with green/yellow discharge, bacterial sinusitis may require an antibiotic.
Q3: What is the primary difference between first-generation and second-generation antihistamines?
First-generation antihistamines (such as chlorpheniramine) readily cross the blood-brain barrier and cause marked central nervous system sedation and psychomotor slowing. Second-generation antihistamines (cetirizine, levocetirizine, fexofenadine) possess low lipid solubility and cause significantly less sedation.
Q4: Can Montelukast + Levocetirizine (Montair-LC equivalent) be taken long-term for allergic rhinitis?
Montair-LC dual-action therapy is clinically approved for allergic rhinitis and comorbid mild asthma. However, therapy should be re-evaluated periodically by an allergist or ENT specialist to assess clinical necessity and monitor for potential sleep disturbances.
Q5: Are PMBJP Jan Aushadhi allergy medicines therapeutically equal to branded tablets?
Yes. Generic Cetirizine 10mg, Levocetirizine 5mg, and Montelukast 10mg tablets distributed through Jan Aushadhi Kendras comply with Indian Pharmacopoeia monographs and provide equivalent peripheral H1-receptor block at savings exceeding 85%.
This clinical guide is authored and reviewed in accordance with the regulatory standards of the Indian Pharmacopoeia (IP), Central Drugs Standard Control Organization (CDSCO) drug schedules, and Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) bioequivalence guidelines. All therapeutic recommendations and drug interaction warnings are cross-referenced with official statutory publications.
Under India's Digital Personal Data Protection (DPDP) Act, 2023, MediMatch AI functions as a data fiduciary committed to zero retention of private health identifiers. Browsing educational guides, reviewing active salt monographs, and executing search queries occur without tracking or commercial profiling. All client interactions with prescription readers or lab decoders execute ephemerally in volatile memory with zero server-side storage of protected health information (PHI). For inquiries regarding data fiduciary obligations, contact our Data Protection Officer at privacy@medimatchai.in.